Related Experiment Videos
Gene therapy for genetic diseases
1Department of Human Genetics, Mount Sinai School of Medicine, New York, New York 10029, USA. Desnick@vaxa.crc.mssm.edu
Acta Paediatrica Japonica : Overseas Edition
|August 8, 1998
Summary
Gene therapy offers permanent cures for genetic diseases by delivering functional genes. Effective delivery via viral or non-viral vectors remains a key challenge for successful therapeutic outcomes.
Area of Science:
- Biotechnology
- Molecular Biology
- Genetics
Background:
- Gene therapy holds promise for curing genetic disorders.
- Effective gene delivery to target cells is a significant challenge.
- Current strategies involve viral and non-viral vectors for in vivo and ex vivo applications.
Purpose of the Study:
- To review and compare various gene delivery systems for gene therapy.
- To discuss the advantages and disadvantages of different vector types.
- To explore the current status and future of human gene therapy trials.
Main Methods:
- Review of existing literature on gene delivery vectors.
- Comparison of viral vectors (retroviruses, adenovirus, AAV, herpesvirus).
- Analysis of non-viral vectors (liposomes, DNA-protein conjugates).
Main Results:
- Viral vectors like retroviruses, adenovirus, AAV, and herpesvirus are extensively studied.
- Non-viral methods include liposomes for plasmid DNA delivery and DNA-protein conjugates for receptor-mediated uptake.
- Each system presents unique advantages and disadvantages for gene delivery.
Conclusions:
- Overcoming gene delivery obstacles is crucial for advancing gene therapy.
- Continued research into vector development is essential for therapeutic success.
- Human gene therapy trials are progressing, with ongoing evaluation of safety and efficacy.